Drcom Announces a Global Digital Platform for the Pharmaceutical Sector with the Expansion of the NYC Office
Drcom Group, a leading digital marketing and communications agency specializing in the healthcare and life sciences industry, announces the opening of a new office in NY. This will empower Drcom to provide a Global Media platform for the Healthcare sector with localized content development to address regional markets.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181203005179/en/
Drcom announces Global Digital Platform for the Pharmaceutical sector with the expansion of the NYC office (Graphic: Business Wire)
The expansion gives Drcom the ability to offer a global digital marketing platform to the healthcare and life sciences industry. As healthcare is rapidly advancing, clear effective medical communications and content distribution is becoming a key factor on a global basis.
Staffed with dedicated senior account managers and a digital strategy team, the NY team will provide digital marketing insights to the healthcare community. Leveraging its Asian digital marketing platform, the NY office will build on its current pharmaceutical clients. The team is excited to bring its extensive expertise to the US market. As a relationship driven agency, Drcom, can bring high value healthcare content with the ability to provide specifically targeted digital media channels.
Drcom US will also be offering its global customers consulting services and expert insights to support their digital communication strategy in Asia-Pacific and other regions.
The US expansion is being led by Robin Roumengas (https://www.linkedin.com/in/robin-roumengas-8287b851), a founding member of Drcom Group and entrepreneur at heart. Robin previously held the role of Managing Director of Drcom China for 3 years. "The Asian digital ecosystems are today the most advanced in the world. In Asia, social media technology is having a profound effect on the way medical content is being distributed. Healthcare providers are using WeChat to access personalized medical information immediately. Our mission is to provide the best digital expertise at local price and with a global mindset."
Robin is joined in this endeavor by David Rowe (https://www.linkedin.com/in/david-rowe-4a65561), Vice President of Business Development. David has a background in biotechnology and was the founder of a company in the gene therapy area, Excision BioTherapeutics (https://excisionbio.com). “The New York City office represents the global marketing platform enabling the future of digital communication. With pharmaceuticals being global brands, Drcom now offers a global digital brand solution.”
With this new U.S. office, Drcom Group also further strengthen its key strategic partnership with Veeva Systems. “For over 6 years now, Drcom has been a multichannel partner in Asia and one of only a few in the region certified in all multichannel products,” said Zachary Adamerovich, Program Manager at Veeva Systems. Drcom has seen that the use of digital information among doctors has grown as visits by pharma sales reps continue to decline. This is a challenge that Drcom highlighted in their successful presentation on the 4th September 2018 at the 2nd edition of the Veeva Agency Day event hosted by Veeva System China. China has become a force to be reckoned with in digital technologies at home and around the world. As China digitizes, the healthcare industry experiences huge shifts in their model. Healthcare brands cannot survive there anymore without a strong digital strategy. Because Drcom helps build and deploy healthcare brands in Asia and China, Drcom is poised to extend its partnership with Veeva Systems in the U.S and bring the benefit of this experience to our shared customers here.
Drcom clients are top pharmaceutical and life sciences players, of which many are based in the US such a AbbVie, Abbott, Amgen, Bristol-Myers Squibb, Eli Lilly, Janssen, Merck, Pfizer and Procter & Gamble. Other top international clients include Boehringer Ingelheim, AstraZeneca, Sanofi, Nestlé and Bayer.
Besides this new office, Drcom serves its clients from its Shanghai, Beijing, Hong-Kong, Tokyo, Singapore and Ho Chi Minh City offices. With 2 other offices due to open early next year in Australia and Europe, Drcom Group has big and ambitious plans for 2019.
If you wish to reach out to Drcom U.S and meet our team of our experts, contact us (https://www.drcomgroup.com/en/contact).
View source version on businesswire.com: https://www.businesswire.com/news/home/20181203005179/en/